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Background. Optimal use of mass/targeted screen-and-treat or mass or focal drug administration as malaria elimination strat-
egies remains unclear. We therefore studied spatial distribution of Plasmodium falciparum infections to compare simulated effects of 
these strategies on reducing the parasite reservoir in a pre-elimination setting.
Methods. P.  falciparum rapid diagnostic tests (RDTs) and molecular (polymerase chain reaction [PCR]) and serological 
(enzyme-linked immunosorbent assay) analyses were performed on finger-prick blood samples from a population-based survey in 
3 adjacent communities.
Results. Among 5278 persons screened, 13 (0.2%) were positive by RDT and 123 (2.3%) by PCR. PCR-positive individuals 
were scattered over the study area, but logistic regression analysis suggested a propensity of these infections to cluster around RDT-
positive individuals. The odds ratios for being PCR positive was 7.4 (95% confidence interval, 2.8–19.9) for those living in the house-
hold of an RDT-positive individual and 1.64 (1.0–2.8; P = .06) for those living within <300 m, compared with >1000 m. Treating 
everyone within households of RDT-positive individuals (1% population) would target 13% of those who are PCR positive. Treating 
all living within a radius of <300 or <1000 m (14% or 58% population) would target 30% or 66% of infections, respectively. Among 
4431 serologically screened individuals, 26% were seropositive. Treating everyone within seropositive households (63% population) 
would target 77% of PCR-positive individuals.
Conclusions. Presumptive malaria treatment seemed justified within RDT-positive households and potentially worth consider-
ing within, for example, a radius of <300 m. Serology was not discriminative enough in identifying ongoing infections for improving 
focal interventions in this setting but may rather be useful to detect larger transmission foci.
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Malaria infections may become more focal as transmission 
intensity decreases. In Zanzibar, a pre-elimination setting in 
sub-Saharan Africa, foci of residual P.  falciparum transmission 
are primarily identified through passive detection and reporting 
of malaria-confirmed patients presenting at public health facili-
ties. In such foci, or simply in proximity to parasitologically con-
firmed malaria cases, targeted interventions may be considered to 
reduce the reservoir of asymptomatic and low-density infections 
[1–4]. These infections pose a risk for onward transmission [5–7] 
and therefore constitute a potential barrier for malaria elimina-
tion [8]. Mass or focal screening and treatment (MSAT or FSAT) 
and mass or focal drug administration (MDA or FDA) represent 
important options for such targeted strategies. In Zanzibar, a 
reactive FSAT strategy has been in place since 2012. Its aim is to 
identify and treat asymptomatic parasite carriers, and it involves 
performing rapid diagnostic tests (RDTs) in all household mem-
bers of patients with parasitologically confirmed malaria diagno-
ses at public health facilities. This intervention could potentially 
also include households surrounding the index house.
The efficiency of FSAT will largely depend on the existence 
and characteristics of spatial clustering of malaria infections, 
but data on spatial distribution of infections with especially low 
parasite density in the context of malaria elimination are scarce. 
In 1 high-endemicity area in Tanzania, low-density infections 
tended to accumulate within a hot-spot area and within infected 
households [9]. In lower-endemicity areas, findings of a study in 
Cambodia suggested some clustering of low-density infections 
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along the main river [10], and 2 studies from Zambia and Kenya 
have suggested some clustering within infected households [11, 
12]. The effectiveness of FSAT will also depend on the sensitivity 
of the malaria diagnostic tool, and in Zanzibar as elsewhere, RDTs 
will miss a large proportion of low-density infections [13, 14].
Molecular diagnostic tools such as polymerase chain reaction 
(PCR) have much higher sensitivities than RDT or microscopy 
[7, 15, 16] but require high-quality laboratory conditions and 
expensive equipment and are not suitable for point-of-contact 
diagnosis. More field-friendly alternatives, such as loop-me-
diated isothermal amplification, may overcome some of these 
issues [17–21] but remain more expensive than RDTs and are 
not yet applicable to routine community malaria testing.
An alternative screening approach is using serological 
indices, which measure Plasmodium-specific antibodies that 
develop after exposure to infection. Serology could potentially 
be used to identify individuals or households at increased risk 
of infection [22, 23] and thus possible targets for presumptive 
treatment, that is, FDA.
In 2012, an MSAT campaign using P. falciparum–specific 
RDT took place in a malaria hot-spot area in Zanzibar [13]. 
A  postcampaign molecular screening of the same survey 
samples identified a large proportion of low-density P.  fal-
ciparum infections that were not detected by RDT. In the 
present study, we assessed the spatial distribution of these 
PCR-determined infections in relation to the RDT-detected 
infections. We also investigated the implications this distri-
bution may have for different FSAT and FDA approaches, 
and we assessed the usefulness of serological analyses as a 
screening tool to detect and identify individuals or house-
holds at risk of exposure to infection.
METHODS
Study Area and Sample Collection
Zanzibar is a semiautonomous archipelago located approx-
imately 35 km from the coast of mainland Tanzania. It is a 
malaria pre-elimination setting with temporally and spatially 
clustered transmission. This study is based on a subset of data 
from 2 rounds of MSAT undertaken in May and June 2012. 
The MSAT and results have been described elsewhere [13]. 
Briefly, the MSAT was undertaken in malaria hot spots iden-
tified through passive health facility–based surveillance sys-
tems. Screening took place in 5 shehias (administrative units). 
To allow for detailed spatial analyses, the present study is based 
on the data from the 3 geographically adjacent shehias (Bungi, 
Tunguu, and Jumbi; 2012 census population, 10 015 persons) in 
Central district, Unguja island (Figure 1). The screening teams 
recorded 6459 persons from 1625 households. The location of 
each house was recorded using hand-held global positioning 
system devices (Garmin).
All household members present and consenting at the time 
of study visit were screened using a P. falciparum–specific RDT 
(Paracheck Pf; Orchid Biomedical Systems) and treated with 
artesunate-amodiaquine if results were positive. Significant 
ongoing clinical symptoms were recorded, including fever. 
Finger-prick blood samples were also collected on filter paper 
for subsequent PCR (both rounds) and serological (first round 
Figure 1. Location of study sites in Unguja island, Zanzibar.
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only) analyses. Filter papers were stored in individually sealed 
bags with desiccant at 4°C until use.
Laboratory Methods
PCR Analyses
PCR analyses took place in Sweden, as described elsewhere 
[13]. Briefly, the Chelex boiling method [24] was used to extract 
DNA from a 3-mm-diameter dry blood spot punch corre-
sponding to 3–5 µL of blood. Cytb-qPCR with the SYBR Green 
real-time PCR assay, targeting the Plasmodium cytochrome b 
gene [25] was used for infection detection. An 18S quantitative 
PCR method was used thereafter for parasite density quantifi-
cation in all PCR-positive samples [26]. Because the RDT used 
was P. falciparum specific, the results in this study focus only on 
P. falciparum.
Serological Analysis
Antibodies to P. falciparum AMA-1 and MSP-119 were measured 
using enzyme-linked immunosorbent assay [27]. A  threshold 
for seropositivity to each antigen was determined using mix-
ture model methods [28]. The enzyme-linked immunosorbent 
assay output was converted into an age-adjusted antibody 
response [29]. Briefly, LOESS lines were assessed to determine 
the age at which the relationship between log antibody titer (for 
each antigen separately) and age became nonlinear. Individual 
responses were then assigned residuals from linear regression 
of log antibody titer and age for their age category. Assuming 
a homogenous distribution of risk, residuals <0 represent indi-
viduals with lower-than-average antibody titers for their age, 
and residuals >0 represent those whose responses were higher 
than average. Serological analyses were undertaken for the first 
round of MSAT only.
Data Analyses
Clustering of PCR-Positive Around RDT-Positive Individuals
Because matched samples were not obtained for all residents 
during the 2 rounds of screening, the data were merged so that 
each individual had a single RDT and PCR result. For individ-
uals with data from both rounds, the result from the first sur-
vey was used. This ensured that every individual had an equal 
probability of being positive by PCR or RDT. In this merged 
data set, 2 of the RDT-positive individuals were negative by 
PCR [13]. They were left in the analyses, however, to simulate 
field programmatic conditions and also because they may rep-
resent circulating antigen from a recent infection [30] and may 
be indicative of clustering.
To assess distance associations of PCR-positive around 
RDT-positive individuals, the straight-line distance to the 
nearest RDT-positive individual in kilometers was calculated 
for each person and included as a term in a logistic regression 
model, with PCR result (positive or negative) as the outcome. 
A household-level random effect was included to account for 
correlation between individuals within the same house. A linear 
fit of distance was compared with a quadratic fit. Distance from 
RDT-positive individuals was also investigated as a categorical 
variable (within household or within a radius from households 
of 100, 100–300, 300–1000, or >1000 m).
Clustering of Serological Responses Around RDT-Positive Individuals
Antibodies to malaria antigens indicate previous exposure to 
infection. To assess whether such exposed individuals were 
clustered around RDT-positive individuals, we examined the 
relationship between seroprevalence and age-adjusted anti-
body titer of AMA-1 and MSP-119 markers with distance to 
the RDT-positive individual. A  high antibody response is 
more likely to represent a current or recent infection. Only 
those who had experienced historic transmission (ie, were 
without active infection and PCR negative) were included 
in this analysis. Distance to RDT-positive individuals was 
explored as a linear, quadratic, and binary (inside or outside 
household of an RDT-positive individual) term. As for the 
PCR-positive clustering analysis, a household-level random 
effect was included.
Simulating Different Antimalarial Treatment Strategies
Two treatment strategies were simulated and compared in 
terms of the proportion of overall infections that would be 
treated: (1) presumptive treatment of all individuals liv-
ing within a given radius of RDT-positive individuals and 
(2) presumptive treatment of seropositive individuals or all 
individuals within their households. The potential impact of 
these strategies on transmission was estimated by simulating 
the proportion of mosquitoes that would become infected 
after implementation of the different treatment strategies. 
Data on infectivity rates were taken from 2 previous studies 
in which the estimated infectivity rates of patent infections 
were increased 4.0-fold [7] and 10.2-fold [31] relative to sub-
patent infections. We assumed that the RDT in our study 
had parasite density limit of detection comparable to that of 
high-quality microscopy in the previous studies. RDT- and 
PCR-positive infections were thus classified as patent, whereas 
RDT-negative and PCR-positive infections were classified as 
subpatent. The impact on transmission was then assessed 
in terms of the proportion of infections in mosquitoes that 
would be avoided with different treatment strategies.
Ethical Considerations
Informed consent was obtained from the head of household 
and from each individual household member. The study was 
considered part of the Ministry of Health malaria surveil-
lance strategy and did not require ethical approval within 
Zanzibar. The laboratory analyses received ethical approval 
through the Regional Ethics Review Board, Stockholm 
(2013/836-32).
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RESULTS
Study Population
A total of 5278 persons from 1625 households with valid global 
positioning system data were screened at least once during the 
2 rounds of MSAT intervention in the 3 shehias. More female 
than male subjects were tested (61% vs 39%) and this imbalance 
was most pronounced in those aged 15–50 years, of whom two-
thirds of those tested were female.
RDT- and PCR-Detectable P. falciparum Infections
A total of 13 individuals (0.2%) from 11 households (0.7%) were 
RDT positive, and 123 individuals (2.3%) from 114 households 
(7.0%) were PCR positive, all recorded as asymptomatic. Eleven of 
the 13 RDT-positive individuals were confirmed positive by PCR. 
The estimated P. falciparum densities of the PCR-positive infec-
tions are presented in Table 1. The median parasite densities were 
262/µL (range, 12–1108/µL) and 2.9/µL (range <0.1 to 16 130/µL) 
for the RDT-positive and RDT-negative infections, respectively.
The spatial distributions of RDT- and PCR-positive individ-
uals are shown in Figure 2. Both the RDT-positive and PCR-
positive individuals were scattered throughout the study area. 
The risk of being PCR positive, however, was negatively linearly 
associated with distance in kilometers to households with RDT-
positive individuals (odds ratio [OR], 0.57; P = .001), although 
no association was found when distance was included as a 
quadratic term. When distance to an RDT-positive individual 
was included as a categorical variable, living within the house-
hold of an RDT-positive represented the highest risk (Table 2), 
with an OR of 7.4 (95% confidence interval [CI], 2.8–19.9) com-
pared with living >1000  m from an RDT-positive household. 
The corresponding OR of living <300 m from an RDT-positive 
household was 1.64 (95% CI, 1.0–2.8; P  =  .06). A  likelihood 
ratio test suggested that including distance to the nearest RDT-
positive household provided a better fit when included as cat-
egorical variable rather than a linear term. Figure 3 shows the 
proportions of individuals screened and infections found as a 
function of distance to RDT-positive households.
Valid serological responses were recorded from 4431 indi-
viduals at the first screening round, of whom 1170 (26.4%) 
were positive for MSP-119 and/or AMA-1 (Table  3), and 63% 
of households tested had ≥1 seropositive individual present. 
Both seropositivity and age-adjusted antibody responses for 
AMA-1 and MSP-119 were higher among RDT- and PCR-
positive individuals than among those with negative test results 
(Figure 4). Hence, 8 of 10 RDT-positive (80%) and 54 of 103 of 
PCR-positive (52%) individuals were seropositive (Figure 4B). 
Conversely, PCR-positive infections were detected in 54 of 1074 
seropositive individuals (5.0%) (Table 2).
Age-adjusted antibody responses to MSP-119 in PCR-negative 
individuals displayed a slightly negative linear relationship 
with distance to RDT-positive individuals (coefficient, –0.02; 
P  =  .01). This relationship was not found with responses to 
AMA-1 when distance was included as a linear, quadratic, or 
binary variable (inside vs outside the household of an RDT-
positive individual). No relationship was found between 
age-adjusted responses to either antigen or distance to nearest 
PCR-positive individual.
Simulating Different Treatment Approaches
The implications and impact of different targeted treatment 
strategies are highlighted in Table  3 and Figure  3. According 
Table  1. Plasmodium falciparum Parasite Densities in 121 PCR- 
Positive individuals as Determined With Real-Time PCR in RDT-Positive 
and RDT-Negative Individuals
Parasite Density,  
Parasites/µL RDT Positive RDT Negative
Nonquantifiable 0 20
0.1–0.9 0 22
1.0–9.9 0 35
10–99 4 24
100–999 5 7
1000–9999 2 1
≥ 10 000 0 1
Abbreviations: PCR, polymerase chain reaction; RDT, rapid diagnostic test.
Figure  2. Spatial distribution of households with rapid diagnostic test (RDT)– 
and/or polymerase chain reaction (PCR)–positive household members.
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to the estimates, a reduction in onward transmission of 28.2%–
44.7% would be achieved by treating only the 13 RDT-positive 
infections (8.9% of PCR-positive infections). Treating all mem-
bers in the RDT-positive households would have targeted 
another 4.1% of infections and prevented a further 3.2%–7.5% 
of mosquito infections. If all living within 1000 m of the RDT-
positive individuals (57.6% of the population) are included, 
65.9% (95% CI, 57.1–73.7) of all PCR-determined infections 
would be treated, and >70% of mosquito infections avoided.
If seropositivity was used as a basis for targeting treatment, 
treating all members of households with ≥1 AMA-1 or MSP-
119 positive individual would have included 62.8% of the pop-
ulation, targeted 76.8% (95% CI, 67.6–83.9) of infections and 
prevented >80% of mosquito infections. A similar impact on 
transmission would require treating all individuals within 1150 
m of an RDT-positive individual (66.8% of the population).
DISCUSSION
FSAT/MSAT or presumptive FDA/MDA strategies have been 
proposed in the context of malaria elimination. We hypothe-
sized that a combination of the 2 concepts may represent a 
useful approach. This study therefore aimed to investigate clus-
tering of PCR-detected infections in and around households 
that would be identified by either RDT or serological screening 
to then analyze and estimate the potential impact of FDA ver-
sus MDA on reducing the asymptomatic PCR-positive P. falci-
parum reservoir and reducing onward transmission.
Although the 123 PCR-positive individuals were scattered 
over the whole study area, results suggest that such infections 
show some propensity to cluster around RDT-positive infec-
tions. Additional clustering at specific locations distant from 
the households, such as rice farms, may have been missed in 
Table 2. Risk of being Plasmodium falciparum Infected (PCR Positive) by 
Proximity to an Identified RDT-Positive Individual or by Serostatus 
Residence or  
Serostatus
PCR Positive  
(95% CI), %
OR  
(95% CI)a
Proximity of residence to RDT-positive individual
 Same household 11.5 (4.2–25.5) 7.4 (2.8–19.9)
 <100-m radius 2.2 (0.7–5.8) 1.2 (0.4–3.3)
 100–300 m 3.4 (2.1–5.4) 1.8 (1.0–3.2)
 300–1000 m 1.9 (1.4–2.6) 1.0 (0.7–1.6)
 >1000 m 1.9 (1.4–2.5) 1.0 (baseline)
Serostatus
 Seropositiveb 5.0 (3.9–6.5) 3.5 (2.2–5.5)
 Seronegative in seropositive 
household
1.3 (0.8–2.0) 0.9 (0.5–1.6)
 Living in seronegative household 1.5 (1.0–2.2) 1.0 (baseline)
Abbreviations: CI, confidence interval; OR, odds ratio; PCR, polymerase chain reaction; 
RDT, rapid diagnostic test.
aUnivariate logistic regression for likelihood of being PCR positive.
bSeropositive to AMA-1 and/or MSP-119.
Figure  3. Proportions of persons included (red), polymerase chain reaction–
determined infections treated (blue), and mosquito infections prevented (upper 
[dark green] and lower [light green] estimates), in relation to distance from rapid 
diagnostic test–positive individuals, estimated by simulated analyses.
Table  3. Impact of Different Simulated Treatment Strategies Based on 
Positive RDT and Serological Screening Results
Treatment Strategy
Persons 
Treated,
%
PCR-Positive 
Infections  
Treated,
%
Mosquito 
Infections 
Avoided, 
%a
All RDT-positive individuals 0.2 8.9 28.2–44.7
All members of households 
with ≥1 RDT-positive 
individual
1.0 13.0 31.4–52.2
All living within given radius of RDT-positive individual
 <100 m 4.4 16.2 34.0–53.9
 <300 m 13.9 30.1 44.9–61.5
 <1000 m 57.6 65.9 73.1–81.2
All individual with positive results
 AMA 19.6 45.7 47.9–50.3
 MSP-119 14.7 41.1 41.8–42.6
 AMA or MSP-119 26.4 56.8 62.0–66.9
All members of households with
 ≥1 AMA-positive individual 49.9 67.0 71.9–77.2
 ≥1 MSP-119–positive 
indivudal
41.6 61.0 64.7–68.8
 ≥1 AMA- or MSP-119–positive 
individual
62.8 76.8 82.6–88.1
Abbreviations: PCR, polymerase chain reaction; RDT, rapid diagnostic test.
aShown as range, with lower estimates assuming infectivity rates in reference [7] and 
higher estimates according to reference [31].
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this household-based survey. In addition, because only about 
67% of recorded persons were screened and infections with 
low parasite density fluctuate from day to day highly [32–35], a 
number of infections were probably undetected in our survey. 
This may have reduced the statistical power to detect additional 
spatial patterns.
The RDT screening, as expected, detected only a small pro-
portion (about 10%) of PCR-positive infections. The simulated 
impact estimates, however, suggest that treating only the 13 
RDT-positive individuals would prevent 28%–45% of onward 
mosquito infections and further transmission, but no impact 
was found on the prospectively recorded clinical malaria cases 
over a 2-month period after the RDT-based MSAT in the 
study area [13]. Several reasons may account for this. First, 
the estimated transmission effect assumes that everyone is 
screened, whereas the RDT screening coverage was only 67% 
of persons. Second, the higher transmission risk from higher 
(RDT-positive) parasite densities (and gametocytemias) may be 
relatively short-lived until densities are reduced by the immune 
system. Third, the possible impact may be diluted by imported 
infections from neighboring shehias or Tanzania mainland. 
Furthermore, studies on the relations of parasite/gametocyte 
densities and malaria transmission have shown conflicting 
results [36].
Spatial clustering of PCR-positive infections around RDT-
positive infections was most apparent within the same house-
hold as the RDT-positive infection, with the odds of being PCR 
positive 7-fold higher than for those living >1000  m from an 
RDT-positive individual. Similar results have been found else-
where [11, 12]. There was also weak evidence that living within 
300  m of an RDT-positive individual was a risk factor. These 
findings support a policy of presumptive treatment of all mem-
bers in households with an RDT-positive individual and poten-
tially within, for example, a 300-m radius of such an individual 
(14% of the population). Such a strategy would have eliminated 
about 30% of PCR-positive infections. Treating individuals 
Figure 4. A, Age-adjusted mean antibody responses for MSP-119 (blue) and AMA-1 (gray) by infection status. B, Proportion seropositive to MSP-119 and AMA-1 by infection 
status. Confidence intervals calculated allowing for clustering within households and shehias. No infection was defined as rapid diagnostic test (RDT) and polymerase chain 
reaction (PCR) negative; patent infection, as RDT positive; and subpatent infection, as PCR positive and RDT negative.
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residing with 300–1000 m of an RDT-positive household did not 
show any added value compared with community-wide MDA. 
A challenge associated with either FDA or MDA is achieving the 
high coverage necessary for successful transmission-reducing 
strategies.
In Zanzibar, malaria surveillance is largely based on weekly 
reporting of RDT-confirmed malaria infections in febrile 
patients from all public health facilities. Although the RDT-
positive infections in our study were asymptomatic, we believe 
that our clustering analyses and conclusions regarding the impact 
of reactive presumptive treatments may possibly be extrapolated 
to the situation of Zanzibar surveillance with reactive response 
to RDT-positive clinical infections. In an area with implemented 
good community case management, the early treatment of 
symptomatic infections and household members would obvi-
ously be especially efficient in preventing transmission.
The serological testing was only partly discriminative in 
identifying PCR-positive individuals or their households. 
Hence only 57% of infections were found among all sero-
positive individuals. This may be explained by the fact that 
seropositivity can be more a reflection of past than of cur-
rent infection, owing to the long half-lives of antibodies, that 
relatively few antigens and low serum dilutions were used in 
the assays, or that false-positive PCR results may be more 
common at low transmission. Treating all households with 
≥1 seropositive member would have covered 77% of PCR-
identified infections but would mean treating 63% of the 
population. A drawback for serological MSAT is also that, at 
least presently, the screening cannot be performed at the point 
of care. Because serological data are more stable measures 
of malaria transmission, they may be used to identify larger 
residual hot-spot areas [37] rather than to identify individuals 
or households at risk.
In conclusion, we showed that PCR-detectable P. falciparum 
infections cluster around RDT-positive individuals and most 
strongly within the infected household. The findings support 
presumptive treatment within households of RDT-positive 
individuals and potentially worth considering within a certain 
radius (eg, 300 m) for purposes of reducing malaria transmis-
sion. Wider large-scale MDA may be required to meet a more 
rapid elimination objective. Serological tests do not presently 
seem to be a feasible MSAT alternative in Zanzibar because they 
were neither discriminative enough to identify individuals or 
households with ongoing infections and transmission nor avail-
able as point-of-care tests.
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